Twist Bioscience Corp. (TWST)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Twist Bioscience Corp. (TWST)
Company Performance

Current Price

as of Dec 03, 2024

$50.61

P/E Ratio

N/A

Market Cap

$3B

Description

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Metrics

Overview

  • HQSan Francisco, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerTWST
  • Price$50.61+0.62%

Trading Information

  • Market cap$3.00B
  • Float94.88%
  • Average Daily Volume (1m)1,002,369
  • Average Daily Volume (3m)771,360
  • EPS-$3.60

Company

  • Revenue$312.97M
  • Rev growth (1yr)27.69%
  • Net income-$208.73M
  • Gross margin42.61%
  • EBITDA margin-46.16%
  • EBITDA-$144.47M
  • EV$2.43B
  • EV/Revenue7.76
  • P/EN/A
  • P/S9.38
  • P/B6.30